Azurocidin in gingival crevicular fluid as a potential biomarker of chronic periodontitis.

Dimitrios NalmpantisAsimina GatouIoannis FragkioudakisApostolia MargaritiLemonia SkouraDimitra Sakellari

Published in: Journal of periodontal research (2019)

Azurocidin in GCF is a promising biomarker for periodontal disease. The results of the present study agree with previous studies in the literature showing an up-regulated trend in the levels of azurocidin in periodontitis patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
systematic review
peritoneal dialysis
transcription factor
patient reported outcomes